Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ovarian Neoplasms
  Free Subscription

Articles published in
Proc Natl Acad Sci U S A
    March 2024
  1. HAO L, Boehnke N, Elledge SK, Harzallah NS, et al
    Targeting and monitoring ovarian cancer invasion with an RNAi and peptide delivery system.
    Proc Natl Acad Sci U S A. 2024;121:e2307802121.
    >> Share

    January 2023
  2. SCHROFELBAUER B, Kimes PK, Hauke P, Reid CE, et al
    Discovery of antibodies and cognate surface targets for ovarian cancer by surface profiling.
    Proc Natl Acad Sci U S A. 2023;120:e2206751120.
    >> Share

    October 2022
  3. ZHAO G, Tan Y, Cardenas H, Vayngart D, et al
    Ovarian cancer cell fate regulation by the dynamics between saturated and unsaturated fatty acids.
    Proc Natl Acad Sci U S A. 2022;119:e2203480119.
    >> Share

    September 2022
  4. PRAKASH R, Rawal Y, Sullivan MR, Grundy MK, et al
    Homologous recombination-deficient mutation cluster in tumor suppressor RAD51C identified by comprehensive analysis of cancer variants.
    Proc Natl Acad Sci U S A. 2022;119:e2202727119.
    >> Share

    August 2022
  5. AKTORIES K
    Treatment of ovarian cancer with modified anthrax toxin.
    Proc Natl Acad Sci U S A. 2022;119:e2210179119.
    >> Share

    July 2022
  6. DURU N, Pawar NR, Martin EW, Buzza MS, et al
    Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteases.
    Proc Natl Acad Sci U S A. 2022;119:e2201423119.
    >> Share

    April 2022
  7. OZMADENCI D, Shankara Narayanan JS, Andrew J, Ojalill M, et al
    Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis.
    Proc Natl Acad Sci U S A. 2022;119:e2117065119.
    >> Share

    February 2022
  8. PAFFENHOLZ SV, Salvagno C, Ho YJ, Limjoco M, et al
    Senescence induction dictates response to chemo- and immunotherapy in preclinical models of ovarian cancer.
    Proc Natl Acad Sci U S A. 2022;119.
    >> Share

    November 2021

  9. Correction to Supporting Information for Choi et al., Identifying an ovarian cancer cell hierarchy regulated by bone morphogenetic protein 2.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    June 2021
  10. GU S, Lheureux S, Sayad A, Cybulska P, et al
    Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screening.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    January 2021
  11. XIAO Y, Lin FT, Lin WC
    ACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    December 2020
  12. IWAHASHI N, Ikezaki M, Nishikawa T, Namba N, et al
    Sulfated glycosaminoglycans mediate prion-like behavior of p53 aggregates.
    Proc Natl Acad Sci U S A. 2020;117:33225-33234.
    >> Share

  13. KIM O, Park EY, Kwon SY, Shin S, et al
    Targeting progesterone signaling prevents metastatic ovarian cancer.
    Proc Natl Acad Sci U S A. 2020 Dec 1. pii: 2013595117.
    >> Share

    September 2020
  14. SHON DJ, Malaker SA, Pedram K, Yang E, et al
    An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins.
    Proc Natl Acad Sci U S A. 2020;117:21299-21307.
    >> Share

    August 2020
  15. HABER T, Cornejo YR, Aramburo S, Flores L, et al
    Specific targeting of ovarian tumor-associated macrophages by large, anionic nanoparticles.
    Proc Natl Acad Sci U S A. 2020;117:19737-19745.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016